These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R. Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313 [Abstract] [Full Text] [Related]
3. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux. Miner PB. Aliment Pharmacol Ther; 2006 Mar 15; 23 Suppl 1():25-32. PubMed ID: 16483267 [Abstract] [Full Text] [Related]
4. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Dickman R, Parthasarathy S, Malagon IB, Jones P, Han B, Powers J, Fass R. Aliment Pharmacol Ther; 2007 Jul 01; 26(1):41-8. PubMed ID: 17555420 [Abstract] [Full Text] [Related]
5. Duodenogastric and non acid gastro-oesophageal reflux in patients with reflux oesophagitis. Mattioli S, Felice V, Pastina M, Pilotti V, D'Ovidio F, Bacchi ML, Gozzetti G. Hepatogastroenterology; 1995 Jul 01; 42(4):360-6. PubMed ID: 8586369 [Abstract] [Full Text] [Related]
6. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Fiorucci S, Distrutti E, Di Matteo F, Brunori P, Santucci L, Mallozzi E, Bigazzi U, Morelli A. Am J Gastroenterol; 1995 Feb 01; 90(2):270-6. PubMed ID: 7847299 [Abstract] [Full Text] [Related]
7. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Gut; 2008 Aug 01; 57(8):1056-64. PubMed ID: 18403496 [Abstract] [Full Text] [Related]
8. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms. Blonski WC, Shih GL, Brensinger CM, Katzka DA, Metz DC. Scand J Gastroenterol; 2006 Apr 01; 41(4):382-9. PubMed ID: 16635904 [Abstract] [Full Text] [Related]
9. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M, Manno M, De Micheli E, Savarino V. Dig Liver Dis; 2006 Sep 01; 38(9):643-8. PubMed ID: 16627016 [Abstract] [Full Text] [Related]
10. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. McDougall NI, Johnston BT, Collins JS, McFarland RJ, Love AH. Eur J Gastroenterol Hepatol; 1997 Dec 01; 9(12):1161-7. PubMed ID: 9471021 [Abstract] [Full Text] [Related]
11. Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. Emerenziani S, Cicala M, Zhang X, Ribolsi M, Caviglia R, Guarino MP, Sifrim D. Neurogastroenterol Motil; 2007 Jun 01; 19(6):459-64. PubMed ID: 17564627 [Abstract] [Full Text] [Related]
12. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on. Pace F, Bollani S, Molteni P, Bianchi Porro G. Dig Liver Dis; 2004 Feb 01; 36(2):111-5. PubMed ID: 15002817 [Abstract] [Full Text] [Related]
13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Gerson LB, Boparai V, Ullah N, Triadafilopoulos G. Aliment Pharmacol Ther; 2004 Sep 15; 20(6):637-43. PubMed ID: 15352912 [Abstract] [Full Text] [Related]
14. 24-h recording of intragastric pH: technical aspects and clinical relevance. van Herwaarden MA, Samsom M, Smout AJ. Scand J Gastroenterol Suppl; 1999 Sep 15; 230():9-16. PubMed ID: 10499456 [Abstract] [Full Text] [Related]
15. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT, Silberg DG. Aliment Pharmacol Ther; 2007 Mar 01; 25(5):617-28. PubMed ID: 17305763 [Abstract] [Full Text] [Related]
17. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Katz PO. Aliment Pharmacol Ther; 2006 Mar 01; 23 Suppl 1():3-11. PubMed ID: 16483265 [Abstract] [Full Text] [Related]
18. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. López-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J, Sifrim D. Pediatrics; 2006 Aug 01; 118(2):e299-308. PubMed ID: 16831894 [Abstract] [Full Text] [Related]
19. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease. Carmagnola S, Fraquelli M, Cantù P, Conte D, Penagini R. Scand J Gastroenterol; 2006 Jul 01; 41(7):767-72. PubMed ID: 16785188 [Abstract] [Full Text] [Related]
20. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results. Roman S, Serraj I, Damon H, Mion F. Neurogastroenterol Motil; 2007 Jul 01; 19(7):562-8. PubMed ID: 17593137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]